Cumberland Pharmaceuticals Inc. logo

Cumberland Pharmaceuticals Inc.

CPIX | NASDAQ
Chart Builder DCF Calculator
$8.08
+$0.49 (+6.46%)
Sep 22, 2026, 2:14 PM ET · Market open

Market Data

Market Cap
$113.72M
Enterprise Value
$114.57M
Beta
0.10
Average Volume
113.51K
Shares Outstanding (Diluted)
14.98M
Shares Change YoY
0.14%
Institutional Ownership
18.46%
Exchange
NASDAQ
ISIN
US2307701092

Price Performance

Price Change 1M
-1.0%
Price Change 3M
30.2%
Price Change 6M
126.6%
Price Change YTD
90.7%
Price Change 1Y
135.0%
Price Change 3Y
235.8%
Price Change 5Y
176.0%
1M CAGR (ann.)
-2.7%
1Y CAGR (ann.)
195.3%
5Y CAGR (ann.)
28.6%
All-Time CAGR
-3.1%

Valuation

PE Ratio
-10.69
Forward PE
N/A
PEG Ratio
0.08
Forward PEG
0.08
PS Ratio
3.64
Forward PS
3.00
PB Ratio
6.52
P/FCF Ratio
111.20
P/Adj. FCF Ratio
238.04
P/OCF Ratio
151.80
EV/Sales
3.66
EV/EBIT
-12.29
EV/EBITDA
-20.29
EV/FCF
112.03
Earnings Yield
-9.3%
FCF Yield
0.9%
Adj. FCF Yield
0.4%

Financial Health

Net Cash
$3.86M
Total Debt
$4.71M
Cash & Short-Term Investments
$3.86M
Total Assets
$62.88M
Current Ratio
0.96
Quick Ratio
0.96
Debt / Equity Ratio
0.27
Debt / EBITDA
-0.84
Debt / FCF
4.61
OCF / Debt
0.24
Interest Coverage
-31.13
Altman Z-Score
0.70
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
83.4%
Operating Profit Margin
-30.8%
EBITDA Margin
-18.1%
Net Profit Margin
-33.9%
FCF Margin
3.3%
Adj. FCF Margin
1.5%
SBC / Revenue
1.4%
SBC Impact (per share)
-53.3%

Returns

Return on Assets
-16.9%
Return on Equity
-47.1%
Return on Invested Capital
-34.1%
Return on Capital Employed
-34.8%
Return on Tangible Assets
-16.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
-8.4%
Revenue CAGR 5Y
-4.4%
Revenue CAGR 10Y
0.1%
EPS CAGR 3Y
1.8%
EPS CAGR 5Y
-10.7%
EPS CAGR 10Y
-6.8%
FCF CAGR 3Y
-49.5%
FCF CAGR 5Y
-26.4%
FCF CAGR 10Y
16.6%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
23.0%
Revenue Growth Next 3Y
5.7%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
-$0.13
EPS Growth Est (next Q)
116.7%
Revenue Est (next Q)
$8.5M
Revenue Growth Est (next Q)
2.5%

Cash Flow

Operating Cash Flow
$1.14M
Free Cash Flow
$1.02M
Adj. Free Cash Flow
$477.75K
FCF Per Share
-$0.07
OCF Per Share
$0.05
OCF/S Ratio
2.4%

Income Statement

Revenue
$31.27M
Gross Profit
$26.1M
Operating Income
$-9.63M
EBITDA
$-5.65M
Net Income
$-10.61M
EPS (Diluted)
-$0.71
Revenue / Employee
$355.33K
Profit / Employee
$-120.53K
Employees
88

© 2026 bestshares.com. All rights reserved.